ARTA
IMUX icon

A.R.T. Advisors’s Immunic IMUX Stock Holding History

A.R.T. Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-46
Closed -$52K – 1487
2017
Q2 		$52K Buy
+46
New +$61.4K ﹤0.01% 1299
2017
Q1 		– Sell
-38
Closed -$66K – 1554
2016
Q4 		$66K Buy
+38
New +$83.2K ﹤0.01% 1196
2016
Q3 		– Sell
-34
Closed -$84K – 876
2016
Q2 		$84K Buy
+34
New +$112K ﹤0.01% 1224
2015
Q4 		– Sell
-268
Closed -$432K – 1577
2015
Q3 		$432K Buy
+268
New +$1.34M 0.02% 933

Other funds holding IMUX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

A.R.T. Advisors's IMUX Position: Q3 2017 in Review

A.R.T. Advisors sold out of Immunic (IMUX) in Q3 2017, closing a stake of 46 shares — an estimated $52K sold.

A.R.T. Advisors first reported a position in IMUX in Q3 2015 and held it in 4 quarters. The position peaked at $432K in Q3 2015. 42 funds tracked by Wall St. Rank hold IMUX as of Q3 2017.

  • A.R.T. Advisors reported no remaining Immunic position as of Q3 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 46 Immunic shares in Q3 2017, an estimated $52K.
  • A.R.T. Advisors first reported a position in Immunic in Q3 2015 and held it in 4 quarters.
  • A.R.T. Advisors's Immunic position peaked at $432K in Q3 2015.
  • 42 funds tracked by Wall St. Rank held Immunic as of Q3 2017.

Based on A.R.T. Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.